Pharma & Biotech News #PharmaBuzz

Market Place

Sourcing Support

Weekly News Recap #Phispers

J&J's 2026 sales may cross US$ 100 bn; FDA delays fast-track reviews of drugs under Trump's voucher program

In 2022, Pfizer had crossed US$ 100 billion in revenue owing to its Covid products. While that was a one-off, Johnson & Johnson...

Impressions : 775

AbbVie inks US$ 5.6 bn oncology deal with China's RemeGen; Astra buys Modella AI to speed up cancer drug research

This week’s Phispers is packed with news from the ongoing JP Morgan Healthcare Conference (JPM26). Notably, AbbVie said i...

Impressions : 1058

Sanofi, Earendil Labs ink up to US$ 2.56 bn AI-driven autoimmune drug deal; CDC revises childhood immunization guidelines

The New Year began with two mid-size deals centered around the use of artificial intelligence (AI) in drug development. Sanofi...

Impressions : 856

BioMarin inks US$ 4.8 billion rare disease deal with Amicus; FDA approves pill version of Novo's Wegovy

PharmaCompass wishes its readers a very Happy New Year and brings news from the last two weeks in this double-dose edition of...

Impressions : 1136

Only few entries up to this point, click to access all

Quality Compliance Alerts #Warning!

All News #Library

Generics

Biotech

APIs

Quality

Sciences

Rare Diseases

Others

NEWS

DRUGS & DEVELOPMENTS

MARKET INTEL by PharmaCompass

J&J's 2026 sales may cross US$ 100 bn; FDA delays fast-track reviews of drugs under Trump's voucher program

AbbVie inks US$ 5.6 bn oncology deal with China's RemeGen; Astra buys Modella AI to speed up cancer drug research

Sanofi, Earendil Labs ink up to US$ 2.56 bn AI-driven autoimmune drug deal; CDC revises childhood immunization guidelines

BioMarin inks US$ 4.8 billion rare disease deal with Amicus; FDA approves pill version of Novo's Wegovy

Shandong's Generics Oxaliplatin Receives Approval in US

Msn's Generics Eltrombopag Olamine Receives Approval in US

Somerset' s Generics Eltrombopag Olamine Receives Approval in US

Orbicular's Generics Liraglutide Receives Approval in US

Sandoz's Generics Sitagliptin Phosphate Receives Approval in US

Amneal's Generics Eltrombopag Olamine Receives Approval in US

Zyd Pharms' Generics Eltrombopag Olamine Receives Approval in US

Amneal's Generics Sodium Bicarbonate Receives Approval in US

Ascent Pharms' Generics Topiramate Receives Approval in US

Respirent' Generics Fluticasone Propionate Receive Approval in US

Enforcement Report - Week of January 21, 2026

Enforcement Report - Week of January 14, 2026

Winder's Receives FDA Warning Letter

Chemspec Chemicals' Receives FDA Warning Letter

Purushothaman Damodara Kumaran's Receives FDA Warning Letter

Modern Recalls "Modern Warrior Ready" Dietary Supplement

Anthony Trinh Issues Nationwide Recall of Silintan Capsules

Asanuma Corporation is on FDA Import Alert List

FDA Issues Form 483 to Pure Indulgence Aesthetics

PLZ Corp. is on FDA Import Alert List

Bausch's $2B pursuit of Xifaxan successor hits wall Ph 3 failure

US Vaccine Panel Head Questions Polio Recommendation

Novo's Wegovy pill hits over 18,000 US prescriptions in Debut

BMS pens $850M tumor pact with T-cell engager biotech Janux

Samsung Bio ekes ahead of Korea biopharma peers with great 2025

US withdraws from the World Health Organization

Boundless Scraps Combo Treatment Of 2 Unimpressive Cancer Drugs

Corxel secures $287M series D to fund oral GLP-1 studies

Lexicon Opens Path to $1B+ Opportunity as FDA Greenlights Phase

NIH bans use of aborted fetal tissue in research

Aspire Biopharma Files Patent for Sublingual Generic Xanax(R)

SEC Recommends Three Firms For Semaglutide Formulations

Zydus Lifesciences Gets USFDA Nod For Generic Blood Disorder Drug

Zydus Receives Final Approval From USFDA For Eltrombopag Tablets

Apiject Opens U.S. Generic Injectable Facility in Apex, NC

Altanine's Outlook on Generics and Value-Added Formulations

Dr. Reddy's Announces First-to-Market Launch of Olopatadine HCl

Bionpharma Gets USFDA Nod For Etravirine Tablets With Steerlife

Allos Secures $5M For Causal AI In Drug Reformulation

Alembic Announces USFDA Tentative Approval For Bosutinib Tablets

US Vaccine Panel Head Questions Polio Recommendation

BMS pens $850M tumor pact with T-cell engager biotech Janux

Samsung Bio ekes ahead of Korea biopharma peers with great 2025

Boundless Scraps Combo Treatment Of 2 Unimpressive Cancer Drugs

FDA Outlines Draft Policy On MRD For Accelerated Approval

Merck, Moderna Sustain 49% Melanoma Risk Reduction At 5 Years

Experimental Drug Scores In Ph. 3 For Painful Sunlight Disorders

Zura Bio Appoints Immunology Leader Sandeep Kulkarni, MD, as CEO

BD And Ypsomed Expand Biologics Partnership For Market Growth

FDA Grants Wugen BTD for WU-CART-007 in R/R T-ALL/T-LBL Lymphoma

HRV Pharma, Haleos Labs Partner on Partner on Orphan & niche APIs

CDSCO OKs Most New r-DNA Drugs for 2025 Import & Manufacture

Sigachi Industries Reaches Key R&D Milestone In Cystic Fibrosis

Indian Pharma Urges Supply Chain Overhaul Amid Rising Tensions

Agno Pharma Acquires Actylis's CDMO Manufacturing Asset

Life Sciences Industry Urges Cybersecurity Funding, PLI Policy

Pharma, Med-Tech Firms Seek PLI Extension For APIs Coverage 2026

Supriya Lifescience Boosts Capacity And Global Readiness

How to Choose a Reliable Oxytetracycline HCL API Manufacture

HRV Pharma Redefines India's Bulk Drug Business with a Virtual Ph

NIH bans use of aborted fetal tissue in research

Corcept's cancer drug cuts risk of death in ovarian cancer trial

Over 160 Drug Samples Found Sub-Standard In December

LOTTE Biologics Strengthens Global Quality With Syracuse ADC Hub

FDA Proposes Febrile Seizure Warnings on Flu Shot Labels

FDA Observation to Hit Lanreotide supply; Cipla may face earnings

Former Emergent CEO Hit With Insider Trading Lawsuit

Experts Urge Scrutiny of Fake ISO Certs for Medical Devices

Compounder Sues Lilly, Novo, Claims Coordinated Crackdown

IPA-CPD Urges Health Ministry To Mandate Red Line On Antibiotic

Pangea Lab, Gene Solutions Advance US Cancer Diagnostics Research

Natera Validates Latitude MRD Test For Colorectal Cancer

Evofem Expands 'Say Vagina' Campaign with Store Launch